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Chronic progressive external ophthalmoplegia (CPEO) is common inmitochondrial disorders and is frequently associated withmultiple
mtDNA deletions. The onset is typically in adulthood, and affected subjects can also present with general muscle weakness. The under-
lying genetic defects comprise autosomal-dominant or recessivemutations in several nuclear genes, most of which play a role inmtDNA
replication. Next-generation sequencing led to the identification of compound-heterozygous RNASEH1mutations in two singleton sub-
jects and a homozygousmutation in four siblings. RNASEH1, encoding ribonuclease H1 (RNase H1), is an endonuclease that is present in
both the nucleus and mitochondria and digests the RNA component of RNA-DNA hybrids. Unlike mitochondria, the nucleus harbors a
second ribonuclease (RNase H2). All affected individuals first presented with CPEO and exercise intolerance in their twenties, and these
were followed by muscle weakness, dysphagia, and spino-cerebellar signs with impaired gait coordination, dysmetria, and dysarthria.
Ragged-red and cytochrome c oxidase (COX)-negative fibers, together with impaired activity of various mitochondrial respiratory chain
complexes, were observed in muscle biopsies of affected subjects. Western blot analysis showed the virtual absence of RNase H1 in total
lysate frommutant fibroblasts. By an in vitro assay, we demonstrated that altered RNase H1 has a reduced capability to remove the RNA
from RNA-DNA hybrids, confirming their pathogenic role. Given that an increasing amount of evidence indicates the presence of RNA
primers duringmtDNA replication, this result might also explain the accumulation of mtDNA deletions and underscores the importance
of RNase H1 for mtDNA maintenance.Accumulation of multiple mtDNA deletions (DmtDNAs) in
skeletal muscle and the brain is themolecular hallmark of a
group of autosomal-recessive or -dominant mitochondrial
encephalomyopathies, characterized by chronic progres-
sive external ophthalmoplegia (CPEO), caused by nuclear
genetic mutations affecting the integrity of the mitochon-
drial genome. This condition is part of a spectrum of
clinically and genetically heterogeneous disorders of inter-
genomic communication; this spectrum also includes
mtDNA depletion syndromes. An increasing number of
genes, encoding components of the mtDNA replisome,
mitochondrial deoxynucleotide supply, mitochondrial
dynamics and quality control, and also proteins of still-un-
known function,1,2 have been associated with this cate-
gory of mitochondrial disorders. Recently, mutations in
DNA2 (MIM: 601810)3 and MGME1 (MIM: 615076),4 en-
coding exonucleases involved in mtDNA repair or matura-
tion, have been described in subjects presenting with
CPEO associated with DmtDNA (CPEO/DmtDNA). We
show here that mutations in RNASEH1 (MIM: 604123), en-
coding an endonuclease specific to RNA-DNA double-
stranded hybrids,5 cause the same syndrome.
We studied two singleton subjects (S1 and S2) and four
affected siblings (S3–S6) (Figure 1A). S1 and S2 developed
juvenile-onset CPEO, muscle weakness and wasting,
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piratory muscles explains the severe nocturnal dyspnea
and orthopnoea in S1. CPEO occurred later in siblings
S3–S6, but their symptoms and progression were similar
and included CPEO, dysphagia, and respiratory impair-
ment. S3, S4, and S5 died at 60, 70, and 63 years of age,
respectively; S6 is now 65 years old, wheelchair bound,
fed by a percutaneous-endoscopic-gastrostomy tube, and
under non-invasive ventilation. All affected individuals
showed cerebellar involvement, secondary to MRI-proven
cerebellar atrophy (Figure 1B). In addition to having CPEO,
affected subjects displayed a number of peculiar features,
e.g., exquisite involvement of respiratory muscles and pro-
gressive ataxia due to severe involvement of the spino-
cerebellar pathways and cerebellar atrophy, which could
be useful clues for diagnosis. Muscle biopsies of all six
subjects showed numerous ragged-red, intensely succinate
dehydrogenase (SDH)-positive, COX-negative fibers (Fig-
ure 1C). Electron microscopy on muscle from S2 showed
extremely elongated, hyperfused mitochondria (Fig-
ure 1D). Spectrophotometric analysis of muscle homoge-
nates from S1 and S2 and myoblasts from S2 showed
partially reduced complex I and IV activities, whereas
values were normal in fibroblasts from S1. Detailed
clinical and biochemical descriptions of the affected indi-
viduals are reported as supplemental case reports (see, UK; 2Unit of Molecular Neurogenetics, Fondazione IRCCS Istituto Neuro-
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Figure 1. Clinical, Morphological, and Genetic Features of Individuals with Mutations in RNASEH1
(A) Pedigrees of individuals with mutations in RNASEH1. Black symbols designate affected subjects, who are numbered according to the
main text. The mutation status of each analyzed family member is indicated and is based on the NCBI RefSeq RNASEH1 transcript.
(B) Brain MRI in S1. T1 sagittal (I) and cross (II) sections show cerebellar atrophy and mild bulbar atrophy in S1.
(C) Histological findings in muscle biopsy from S2. Abbreviations are as follows: COX, cytochrome c oxidase; SDH, succinate dehydro-
genase; Gomori Trichrome, GT. GTstaining shows one ragged-red COX-negative and SDH-positive fiber and several COX-negative fibers.
Scale bars represent 25mm.
(D) Electronmicroscopywith a seamlessmitochondrial network intermingled amongmyofibrils in amuscle biopsy from S2. Arrowheads
indicate ramification of the mitochondrial syncytium. Scale bars represent 0.25 mm in the upper panel and 0.10 mm in the lower panel.
(E) Southern blot analysis of mtDNA obtained frommuscle biopsies of affected individuals S1 and S5, of control subjects (Ct), and of an
individual with POLG1 mutations (Ctþ).
(F) mtDNA levels assessed by qPCR in myoblasts from S2 and three control subjects (Ct). The mean value of the mtDNA/nDNA ratio
obtained in control subjects was set as 1. Error bars represent SDs.Supplemental Data). Informed consent for participation in
this study was obtained from all investigated subjects in
agreement with the Declaration of Helsinki, and the study
was approved by the ethical committees of the centers
where biological samples were obtained. Southern blot
analysis showed multiple DmtDNAs in muscle from
S1–S4 and S6 (no muscle DNA was available for S5)
(Figure 1E). The mtDNA copy number was unchanged
(105% in S2) or increased (300% in S1) in skeletal muscle,
whereas significant mtDNA depletion (16%) was detected
by qPCR in myoblasts from S2 (Figure 1F).
In order to identify the underlying genetic cause in our
probands, we first ruled out several genes known to be
associated with CPEO/DmtDNA syndromes by Sanger
sequencing. We then performed whole-exome sequencingThe Aon DNA from S1; after filtering (Tables S1 and S2), we
searched for homozygous or compound-heterozygous
variants that followed a recessive inheritance pattern
according to the pedigree of S1’s family. From selected pre-
viously unreported or rare variants in genes encoding
known or predicted mitochondrial proteins, we zeroed in
on two changes in RNASEH1 (GenBank: NM_002936.4),
c.424G>A (p.Val142Ile) on the paternal allele and a
nonsense mutation, c.469C>T (p.Arg157*), on the
maternal allele. Next, we screened RNASEH1 in a cohort
of 40 genetically undefined CPEO/DmtDNA-affected indi-
viduals and identified compound-heterozygous mutations
c.424G>A (p.Val142Ile) and c.554C>T (p.Ala185Val) in
S2. S3 was homozygous for the same variant, c.424G>A,
found in S1 and S2; this mutation segregated with themerican Journal of Human Genetics 97, 186–193, July 2, 2015 187
Figure 2. Characterization of the Struc-
ture and Enzymatic Activity of RNaseH1
Variants
(A) Human RNaseH1 (top) consists of
four domains: a mitochondrial targeting
sequence (MTS) that directs the protein to
mitochondria and is cleaved after import,
a hybrid binding domain (HBD) involved
in recognition of DNA-RNA heterodu-
plexes, a catalytic domain responsible for
the cleavage of the RNA component in
the heteroduplex, and a flexible connec-
tion domain (CD) that links the last two
domains. Phylogenetic alignment of the
human protein region containing the sub-
stitutions found in affected individuals is
shown below. Conserved residues that are
altered in affected subjects are boxed in
red and are found near conserved residues
in the active site or interacting with DNA
or RNA in the heteroduplex; these latter
residues are boxed in blue or green, respec-
tively. Abbreviations are as follows: Hs,
H. sapiens; Mm, M. musculus; Bt, B. taurus;
Gg, G. gallus; Xl, X. laevis; Dr, D. rerio; Ci,
C. intestinalis; Dm, D. melanogaster; Ce,
C. elegans; Sc, S. cerevisiae.
(B) RNase H1 activity of recombinant pro-
teins. The portion corresponding to the
mature protein, lacking the mitochondrial
targeting signal (MTS), was cloned into a
pET-28a bacterial expression vector (Nova-
gen) containing an N-terminal His6 tag.
Protein production was carried out in
BL21(DE3)pLysS E. coli cells at 37C in
lysogeny broth medium. Proteins were loaded onto a Ni-NTA agarose column and eluted with 400 mM imidazole. 80 nmol of DNA-
RNA heteroduplex oligonucleodies were incubated with E. coli RNase H1 or either wild-type or altered recombinant proteins for
1 hr.6 Reaction products were loaded onto 15% polyacrylamide gels, and gel imaging and quantification followed.
(C) Relative RNase H1 activity was obtained by quantification of the amount of processed oligonucleotide normalized by protein loading
(based on western blotting; Figure S1C) and relative to wild-type protein. *p < 0.05, ***p < 0.001 (two-tailed unpaired Student’s t test).
n ¼ 3 experiments. Error bars represent 1 SD.disease, given that it was homozygous in affected family
members (Figure 1A). All the identified RNASEH1 variants
were absent or extremely rare (<0.01%) in the Exome Ag-
gregation Consortium (ExAC) Browser (Table S3).
All amino acid changes map to the first third of the
RNase H1 catalytic domain (Figure 2A). p.Arg157* affects
the 22nd residue of the catalytic domain, leading to the
synthesis of a truncated protein lacking catalytic activity,
as proven by in vitro assay (see below). Substitutions
p.Val142Ile and p.Ala185Val affect amino acids that are
close to conserved residues, are part of the active site, or
interact with RNA or DNA strands (Figure 2A).
RNASEH1 encodes mitochondrial and nuclear protein
variants, depending on which initiation AUG codons, en-
coding Met1 or Met27, are adopted. An upstream AUG,
encoding Met0, competes with initiation at Met1 (which
begins the mitochondrial variant), so that in physiological
conditions, the nuclear form (which starts with Met27) is
predominant.7 An N-terminal MTS targets this protein to
mitochondria and is eventually cleaved off by the mito-
chondrial matrix peptidase after translocation, resulting
in a protein almost identical to the nuclear form. A second,
exclusively nuclear ribonucleotidase affecting RNA-DNA188 The American Journal of Human Genetics 97, 186–193, July 2, 20hybrids is RNase H2, alterations in which are responsible
for Aicardi-Goutieres syndrome (MIM: 610333, 610181).
To circumvent potential cross-contamination and demon-
strate the effect of the RNASEH1 mutations on protein ac-
tivity, we affinity purified wild-type (WT) and altered forms
of mature human RNase H1 from overexpressing bacterial
strains (Figures 1A and 1B). The in vitro activity of the
recombinant proteins (Figure 2B) was assessed on fluores-
cent-labeled oligonucleotides forming a 6-bp-long DNA-
RNA heteroduplex (Figure S1B). Whereas the WT recombi-
nant protein and E. coli RNase H1 were both able to fully
cleave the RNA from the heteroduplex, the recombinant
p.Val142Ile and p.Ala185Val proteins displayed partial ac-
tivity and left a significant amount of intact single-
stranded and incompletely cleaved oligonucleotides,
similar to those obtained by incubating the WT protein
with the heteroduplex on ice. Similar to the negative
‘‘no-protein’’ control, recombinant truncated p.Arg157*
protein showed negligible activity, as did the p.Asp210Asn
protein, previously reported as catalytically inactive8
(Figure 2C).
To further investigate the molecular consequences of
RNASEH1 mutations, we characterized skin fibroblasts15
Figure 3. Growth and Mitochondrial Alterations in RNASEH1 Mutant Fibroblasts
(A) Western blot analysis, using antibodies against RNASEH1 (Abcam) and SDHA (Mitosciences-Invitrogen), of fibroblasts (fb) from S1
and control subjects (Ct); SDHA was taken as a loading control. Both naive and immortalized (Imm.) fibroblasts were used.
(B) Growth curves of control cells and RNASEH1 cells from S1 in glucose (high-glucose medium) and galactose (glucose-free medium
supplemented with 50 mM galactose). Cell growth was monitored continuously by the IncuCyte live cell imager (Essen Bioscience).
Data represent the average5 SD of three independent experiments.
(C) Mitochondria (red) were stained for 20 min with DP-dependent dye (20 nM TMRM), and DNA (green) was stained with PicoGreen
(3 ml/ml) in live cells grown in glucose or galactose for 5 days. A digitally enhanced TMRM image from RNASEH1mutant fibroblasts from
S1 is shown in Figure S4A.from S1 and two healthy control individuals in permissive
glycolytic-prone medium (containing glucose as the sole
carbon source) or oxidative phosphorylation (OXPHOS)-
obligatory medium (containing galactose instead of
glucose). RNASEH1 transcript levels in cells from S1 were
decreased to 47% or 36% when grown in glucose or galac-
tose, respectively (Figure S2), most likely as a result
of nonsense-mediated mRNA decay of the transcript
harboring the premature stop codon.Western blot analysis
showed the virtual absence of RNase H1 in total cell lysates
from S1 (Figure 3A), suggesting instability of both
p.Arg157* and p.Val142Ile RNase H1 variants. Whereas
glucose-grown cells showed no significant differences, cells
from S1 grew more slowly in galactose than control cellsThe Adid (Figure 3B), suggesting mitochondrial dysfunction.
Accordingly, cell-cycle analysis revealed a significant in-
crease in G1 and G0 phases and a decrease in S phases in
galactose-grown cells from S1 (Figure S3). To further assess
mitochondrial dysfunction, we analyzed mitochondrial
morphology and membrane potential (DP) on live cells
by using tetramethylrhodamine methyl ester (TMRM)
and JC-1 immunofluorescence (Figure 3C). Glucose-grown
cells from S1 displayed a mitochondrial network similar to
that of control cells, albeit the intensity of the staining was
significantly lower and thus indicated reduced DP (Figures
3C and S4A). Flow-cytometry analysis using JC-1 staining
showed a 50% DP decrease in cells from S1 (Figure S4B).
Whereas galactose-grown control cells showed neithermerican Journal of Human Genetics 97, 186–193, July 2, 2015 189
Figure 4. Mitochondrial DNA Copy Number and 7S DNA Mutations in RNASEH1 Mutant Fibroblasts from S1and Muscle from S1
and S2
(A) Total DNA from control and RNASEH1 mutant fibroblasts was digested with PvuII, and mtDNA was analyzed by one-dimensional
Southern blot. Radioactive probes (able to detect both linearized mtDNA and 7S DNA) specific to the human mtDNA D-loop region
(nucleotide positions 16.341–16.151) and 18S ribosomal DNA were applied.
(B) The relative mtDNA copy number (mtDNA/18S rDNA ratio) was obtained after quantification of the Southern blot signal with Phos-
phorImager screens and normalization to control fibroblasts. ***p < 0.001 (two-tailed Student’s t test). n ¼ 2 experiments. Error bars
represent 1 SD.
(C) 7S DNA levels (7S DNA/mtDNA ratio) were obtained after quantification of the Southern blot signal with PhosphorImager screens
and normalization to control fibroblasts. ***p < 0.001 (two-tailed Student’s t test). n ¼ 2 experiments. Error bars represent 1 SD.
(D) 7S DNA levels (7S DNA/mtDNA ratio) in muscle from S1, S2, and subjects with mutations in MGME1 and DNA2 were assessed by
qPCR. Error bars represent 1 SD.alteration in mitochondrial morphology nor DP changes,
cells from S1 displayed perinuclear aggregation of
fragmented mitochondria (Figure 3C) and higher DP
(Figure S4B).
To investigate the effect of RNASEH1 mutations on
mtDNA, we first analyzed nucleoid structure in live cells
from control individuals and S1 by PicoGreen staining.
Glucose-grown fibroblasts from S1 displayed fewer,
smaller, and sharper nucleoids (Figures 3C and S5),
whereas in galactose-grown cells, these differences were
less prominent (Figure 3C), suggesting more active mtDNA
metabolism in OXPHOS-obligatory conditions. Because
PicoGreen staining is dependent on both the amount
and topology of mtDNA,9 and we had observed mtDNA
depletion in S2 myoblasts, we further investigated mtDNA
copy number by Southern blot analysis. Fibroblasts from
S1 showed mild (80% of control mean value) mtDNA
depletion only in glucose, and no DmtDNA was detected
(Figures 4A and 4B). These results were confirmed by
qPCR (Figure S6). However, we observed a >10-fold in-190 The American Journal of Human Genetics 97, 186–193, July 2, 20crease in 7S DNA (Figure 4C), the third strand of the
mtDNA displacement loop (D-loop); mutant muscle also
displayed higher levels of 7S DNA (Figure 4D), suggesting
aborted replication.
Because these results indicated that RNASEH1mutations
affected mtDNA replication, we studied replication inter-
mediates by two-dimensional gel electrophoresis.10–12
Compared to control cells, glucose-grown fibroblasts
from S1 displayed a 2- to 4-fold increased signal (Figures
5A–5C and S7A). New replication intermediates, Y-arc ex-
tensions, located at the end of the Y-arc pause (Figures 5B
and 5C), were detected in fibroblasts from S1. This exten-
sion of the Y-arc might originate as a result of the presence
of persisting RNA between the light-strand promoter and
the conserved sequence block 1 or 2, which would be
removed in control fibroblasts by proficient RNase H1
(Figure 5D).12–14 Fibroblasts from S1 also showed an in-
crease in double-Y intermediates, indicating that replica-
tion paused at ribosomal genes, most likely because altered
RNase H1 failed to efficiently remove rRNA transcripts15
Figure 5. Effect of Mutant RNASEH1 Fibroblasts from S1 on mtDNA Replication
(A) Restriction enzyme sites and position of the probe are labeled. The origin of the H-strand replication (OH) is marked within the non-
coding region (black bar).
(B) mtDNA replication intermediates analyzed by two-dimensional agarose gel electrophoresis and Southern blot. Explanatory cartoons
are provided at the right of each image; shades of gray reflect the different intensities of the signal.
(C) A cartoon based on this and previous work10–14 shows different replication intermediates associated with this fragment and the non-
replicating fragment, 1n.
(D) Proposed models that could explain the presence of a Y-arc extension (left) and increased double-Y (right) mtDNA replication inter-
mediates from RNASEH1mutant fibroblasts from S1. Parental DNA strands are in black, nascent DNA strands are in blue, and RNA is in
red. The L-strand promoter (LSP) and conserved sequence block region (CSB) are marked as reference points.(Figures 5B and 5D). A stronger signal in replication inter-
mediates is consistent with replication slowdown, as also
reported in MGME1 mutations,4 and HEK cells overex-
pressing catalytic alterations of the mtDNA helicase or
polymerase.15 Galactose-grown cells showed decreased sig-
nals of almost all replication intermediates (Figure S7B).
Finally, we performed mtDNA depletion and repopulation
experiments. Glucose-grown cells exposed to the DNA in-
tercalator EtBr for 96 hr showed a decrease of mtDNA
amount to <20% in all cell lines (Figure 6A). Whereas con-
trol cells recovered to initial mtDNA levels in 120 hr, cells
from S1 required 168 hr, indicating a slower replication
rate. Mutations in other genes involved in mtDNA replica-
tion such as POLG1 (MIM: 174763), RRM2B (MIM:The A604712), and MGME1 have also been associated with
slow or virtually no recovery in human fibroblasts.4,16
Active replication was measured as the rate of BrdU incor-
poration in fibroblasts where nuclear replication was in-
hibited with aphidicolin (Figure 6B). Fibroblasts from S1
showed 30% less BrdU incorporation than did control cells
in both glucose and galactose media, indicating slower
mtDNA replication in fibroblasts from S1, most likely due
to stalling caused by RNA tracts not being efficiently
removed by altered RNase H1.14,17
Our findings show that RNase H1 is required for
effective mtDNA replication in humans;18 this has also
been suggested by the embryolethality of an Rnaseh1/
mouse model, which becomes virtually r0 by p.c. 8.5.19merican Journal of Human Genetics 97, 186–193, July 2, 2015 191
Figure 6. mtDNA Replication Is Slowed Down in Mutant RNASEH1 Fibroblasts from S1
(A) mtDNA copy number during depletion and recovery in control and RNASEH1 mutant fibroblasts. Depletion was achieved by
the addition of 100 ng/ml EtBr to the culture medium for 96 hr, and recovery was followed up for 192 hr after the removal
of the drug. mtDNA copy number was determined by qPCR, and each data point represents the mean values from two indepen-
dent determinations 5 SD. Arrowheads indicate the time point at which mtDNA was recovered at or close to initial values for
each cell line.
(B) Detection of newly synthesizedmtDNA. Cells were treated with 20 mMAphidicolin (Sigma) for 6 hr to block nuclear DNA replication.
Total DNA from control and RNASEH1mutant fibroblasts subjected to pulse labeling of mtDNA with BrdU (100 mM) for 0, 1, 3, 6, and
24 hr was digested with NaeI and analyzed by one-dimensional southwestern blot. The BrdU signal was immonodetected with anti-BrdU
antibody (Becton Dickinson) and was followed by mtDNA detection using a radioactive probe specific to the human mtDNA D-loop
region.
(C) Plot of BrdU incorporation (normalized to mtDNA loading) over time; the linear regression for each cell line is shown. Each data
point represents the mean of two replicates5 SD.Deleterious RNASEH1 mutations slow down and stall
mtDNA replication, causing both mtDNA depletion and
deletions and ultimately leading to clinically overt mito-
chondrial disease. Unlike MGME1, which is exclusively
mitochondrial, and similar to DNA2, RNase H1 is localized
in both the nucleus and mitochondria. Nevertheless, its
impairment determines a virtually exclusive mtDNA dam-
age, most likely because of the compensatory role of
nuclear RNase H2. All three enzymes are involved in matu-
ration of mtDNA and possibly in its repair, although RNase
H1 seems to play a direct important role in mtDNA replica-
tion by processing the RNA primers of nascent strands.
This could also explain the accumulation of 7S DNA spe-
cies, given that defective RNase H1 increases the propor-
tion of intermediates with the 7S RNA still attached to
the nascent H strand. This kind of molecule is poorly pro-
cessed by MGME1,4 and that could result in aborted repli-192 The American Journal of Human Genetics 97, 186–193, July 2, 20cation. FENMIT is an exclusively mitochondrial isoform of
FEN1 and also interacts with RNA-DNA hybrids.20 No
mitochondrial diseases have been identified for FENMIT
to date, and the degree of overlap with RNase H1 is not
known. However, we could speculate that FENMIT could
replace RNase H1 in some instances and therefore
contribute to the mild phenotype in subjects with RNase
H1 alterations. According to the analysis of the replication
intermediates by two-dimensional gel electrophoresis,
altered RNase H1 is associated with increased pausing of
the replication fork. Excessive pausing has been proposed
as a mechanism leading to the accumulation of multiple
deleted species and impairment of the replisome machin-
ery either through breakage or recombination,21,22 which
could also explain partial mtDNA depletion and slower re-
covery of mtDNA copy number associated with RNASEH1
mutations.15
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